Accepting new patients

Dr. Patricia Gordon, MD

Radiation Oncology ·  Female · Age 62

Dr. Gordon
468 N Camden Dr, Beverly Hills, CA 90210 Beverly Hills, CA 90210

Make an Appointment

Show Phone Number


Dr. Patricia Gordon, MD is a radiation oncology specialist in Beverly Hills, CA and has been practicing for 37 years. She graduated from David Geffen School Of Medicine At UCLA, University Of California, Los Angeles in 1982 and specializes in radiation oncology and oncology.


Insurance Check

Search for your insurance provider

Dr. Gordon accepts

Accepted insurance can change. Please double-check when making an appointment.

(310) 601-3002

Dr. Gordon accepts the following insurance:

Aetna
Aetna HMO
Basic HMO
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Blue Cross Blue Shield of California
Priority Select HMO
Select Plus HMO
Blue Shield of California
Access Plus Savenet
Local Access Plus HMO
LACare

Background Check

No malpractice claims found for California
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Gordon's experience treating your condition or procedure

Dr. Gordon's Top Procedures and Conditions

Treatment Frequency
Breast Diseases
normal
normal

Treatment Frequency

Dr. Gordon treats Breast Diseases more than 44% of her peers

Dr. Gordon treats this condition more than 44% of her peers

Cancer
normal
normal

Treatment Frequency

Dr. Gordon treats Cancer more than 40% of her peers

Dr. Gordon treats this condition more than 40% of her peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Breast Cancer
normal
normal

Treatment Frequency

Dr. Gordon treats Breast Cancer more than 17% of her peers

Dr. Gordon treats this condition more than 17% of her peers

Rating Includes other areas of care:

  • Angiosarcoma of the Breast
  • Basal Type Breast Cancer
  • Breast Cancer Recurrence
  • Ductal Carcinoma in Situ
  • Inflammatory Breast Cancer
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Locally Advanced Breast Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Malignant Breast Tumor
  • Metastatic Breast Cancer
  • Osteosarcoma of the Breast
  • Pre-Invasive Breast Cancer
  • Radiation-Induced Angiosarcoma of the Breast
  • Secretory Breast Carcinoma
  • Tubular Carcinoma

Dr. Gordon's conditions and procedures:

  • Anal and Rectal Cancer
  • Anal Disorders
  • Anemia
  • Bladder Cancer
  • Blood Disorders
  • Bone Cancer
  • Breast Cancer
  • Breast Cancer Treatment
  • Breast Diseases
  • Cancer
  • Cancer Counseling
  • Cancer Pain Management
  • Cancer Screening
  • Cancer Treatment
  • Cancer Treatment Complications
  • Cancer-Related Conditions
  • Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
  • Chemotherapy
  • Genetic Counseling Services
  • Head and Neck Cancer
  • Intrathecal Chemotherapy
  • Kaposi's Sarcoma
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Multiple Myeloma
  • Neutropenia
  • Non-Hodgkin's Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • PET Scan
  • Prostate Cancer
  • Radiation Therapy
  • Secondary Malignancies
  • Skin Cancer
  • Soft Tissue Sarcoma
  • Urinary Disorders

About Me

Biography

Dr. Patricia Gordon, MD is a radiation oncology specialist in Beverly Hills, CA and has been practicing for 37 years. She graduated from David Geffen School Of Medicine At UCLA, University Of California, Los Angeles in 1982 and specializes in radiation oncology and oncology.

Specialties

  • Radiation Oncology
  • Oncology

Board Certifications

Education

UCLA Med Center
Residency Hospital
1982
David Geffen School Of Medicine At UCLA, University Of California, Los Angeles
Medical School
1982

Languages

  • Chinese
  • Russian
  • Spanish
  • Vietnamese

Awards

Dr. Gordon's Reviews

Likelihood to recommend Dr. Gordon

4.2

Based on 6 reviews

5 Stars
66.66666666666667%
(4)
4 Stars
16.666666666666668%
(1)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
16.666666666666668%
(1)

Leave a review

How likely are you to recommend
Dr. Gordon?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Gordon's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness

Be the first to leave a comment

How was your experience with Dr. Gordon?